Minoxidil

Common brands: Womens Rogaine Unscented, Mens Rogaine Extra Strength Unscented, Minoxidil (For Women), Minoxidil For Women, Kirkland Signature Minoxidil

Top reporter: Kenvue Brands Llc

Arteriolar Vasodilator [EPC]Central Nervous System Stimulant [EPC]Methylxanthine [EPC]Non-Standardized Chemical Allergen [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
44,061
Total Reports
22,100
Serious Reports
446
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (1.01%)

Patient Demographics

Male
23,920
Female
16,894

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Minoxidil.

# Reaction Reports % of Total
1 ADVERSE DRUG REACTION 8,512
17.5%
2 DRUG INEFFECTIVE 7,707
15.8%
3 ALOPECIA 3,766
7.7%
4 APPLICATION SITE PRURITUS 2,909
6.0%
5 OFF LABEL USE 2,247
4.6%
6 OVERDOSE 1,445
3.0%
7 APPLICATION SITE IRRITATION 1,401
2.9%
8 HAIR TEXTURE ABNORMAL 1,397
2.9%
9 APPLICATION SITE PAIN 1,394
2.9%
10 HEADACHE 1,319
2.7%
11 INCORRECT DOSE ADMINISTERED 1,289
2.6%
12 PRODUCT USE IN UNAPPROVED INDICATION 1,173
2.4%
13 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1,167
2.4%
14 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1,150
2.4%
15 PRURITUS 1,001
2.1%
16 PRODUCT USE ISSUE 862
1.8%
17 APPLICATION SITE DRYNESS 813
1.7%
18 RASH 810
1.7%
19 DIZZINESS 799
1.6%
20 PRODUCT FORMULATION ISSUE 792
1.6%
21 APPLICATION SITE ERYTHEMA 759
1.6%
22 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 730
1.5%
23 CONDITION AGGRAVATED 710
1.5%
24 HAIR COLOUR CHANGES 709
1.5%
25 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 696
1.4%
26 HYPERSENSITIVITY 673
1.4%
27 EXPIRED PRODUCT ADMINISTERED 653
1.3%
28 HAIR GROWTH ABNORMAL 650
1.3%
29 APPLICATION SITE EXFOLIATION 611
1.3%
30 DANDRUFF 574
1.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.